According to GVH, the firm acted against regulations when Dr. Fachet attributed beneficial therapeutic or preventive effects to its dietary supplement products Immunforte Basic and Immunforte C+R in its advertisements between January 2013 and August 2014. GCH said that such claims cannot be made in relation to dietary supplement products.